5h
AZoLifeSciences on MSNCombination of Viral Antibodies and Genetic Risk Factors Linked to Increased MS RiskIn multiple sclerosis (MS), antibodies to the common Epstein-Barr virus can accidentally attack a protein in the brain and ...
A new study reveals that men are over twice as likely to develop Parkinson's disease compared to women, due to aggressive T ...
Sen-Jam Pharmaceutical is thrilled to announce the appointment of Dr. Ashley St. John, Ph.D., to its Scientific Advisory Board, further strengthening its commitment to pioneering next-generation, ...
Although there is still no cure for Parkinson's disease, researchers around the world are trying to understand the risk factors involved in its development.
In multiple sclerosis (MS), antibodies to the common Epstein-Barr virus can accidentally attack a protein in the brain and spinal cord. New research shows that the combination of certain viral ...
In multiple sclerosis (MS), antibodies to the common Epstein-Barr virus can accidentally attack a protein in the brain and ...
New research suggests that receiving multiple doses of a vaccine in the same limb leads to faster antibody development, an ...
Poor sleep quality alters immune function, increasing inflammation and disease risk. One night of sleep loss can mimic immune ...
Immunology, Novel Antigens, Preclinical Studies, Multidisciplinary Approaches, Infectious Diseases Important note: All contributions to this Research Topic must be within the scope of the section and ...
The high rate of side effects from oral immunotherapy in the NIH trial explains the superiority of omalizumab. A clinical ...
An international panel of experts has developed standardized definitions and treatment protocols for anaphylaxis, aiming to eliminate long-standing inconsistencies in emergency care. The Global ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results